Amgen Inc.
AMGN
$336.62
$0.330.10%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 8.27% | 9.75% | 10.77% | 13.44% | 16.32% |
| Total Other Revenue | 28.40% | 14.66% | 5.97% | 0.86% | -0.37% |
| Total Revenue | 9.07% | 9.95% | 10.56% | 12.88% | 15.56% |
| Cost of Revenue | 0.45% | 2.42% | 5.35% | 13.84% | 22.84% |
| Gross Profit | 12.92% | 13.38% | 12.94% | 12.46% | 12.57% |
| SG&A Expenses | -0.14% | -0.65% | -0.41% | 2.20% | 11.74% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -123.29% | -28.76% | 124.97% | 542.86% | -5.81% |
| Total Operating Expenses | 5.28% | 6.22% | 11.69% | 13.36% | 18.57% |
| Operating Income | 17.76% | 19.00% | 8.15% | 11.78% | 9.19% |
| Income Before Tax | 36.65% | 94.75% | 76.19% | 110.61% | 53.05% |
| Income Tax Expenses | 79.50% | 143.74% | 175.95% | 103.80% | 23.20% |
| Earnings from Continuing Operations | 31.47% | 88.53% | 65.60% | 111.47% | 57.67% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 31.47% | 88.53% | 65.60% | 111.47% | 57.67% |
| EBIT | 17.76% | 19.00% | 8.15% | 11.78% | 9.19% |
| EBITDA | 7.22% | 9.30% | 4.62% | 11.05% | 13.73% |
| EPS Basic | 31.14% | 88.13% | 65.22% | 110.67% | 56.99% |
| Normalized Basic EPS | 39.29% | 28.19% | 13.17% | 7.93% | -5.35% |
| EPS Diluted | 31.19% | 88.62% | 65.58% | 110.32% | 56.45% |
| Normalized Diluted EPS | 39.45% | 28.26% | 13.21% | 7.81% | -5.61% |
| Average Basic Shares Outstanding | 0.28% | 0.28% | 0.28% | 0.33% | 0.37% |
| Average Diluted Shares Outstanding | 0.18% | 0.28% | 0.32% | 0.51% | 0.70% |
| Dividend Per Share | 5.81% | 5.78% | 5.74% | 5.71% | 5.67% |
| Payout Ratio | -0.19% | -0.44% | -0.36% | -0.50% | -0.33% |